{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:10:29Z","timestamp":1793945429807,"version":"4.8.0"},"reference-count":167,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["74963"],"award-info":[{"award-number":["74963"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biopha.2025.118543","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:47:13Z","timestamp":1757598433000},"page":"118543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Harnessing nanotechnology to modulate hypoxic tumor microenvironments: Enhanced strategies for oncological innovations"],"prefix":"10.1016","volume":"191","author":[{"given":"Vahid","family":"Ghassemifar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azin","family":"Zahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Saeed Soleimani","family":"Meigoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahere","family":"Mokhtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Sahar Mojtaba","family":"Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdis","family":"Parsafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh Kaveh","family":"Zenjanab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana Jahanban","family":"Esfahlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.biopha.2025.118543_bib1","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/onc.2013.121","article-title":"Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment","volume":"33","author":"Casazza","year":"2014","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.biopha.2025.118543_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/156652409788167113","article-title":"Hypoxic tumor microenvironment and cancer cell differentiation","volume":"9","author":"Kim","year":"2009","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.biopha.2025.118543_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ctrv.2018.02.004","article-title":"Targeting the microenvironment in solid tumors","volume":"65","author":"Belli","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.biopha.2025.118543_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-01030-w","article-title":"Targeting hypoxic tumor microenvironment in pancreatic cancer","volume":"14","author":"Tao","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118543_bib5","first-page":"3777","article-title":"Role of hypoxia in inhibiting dendritic cells by VEGF signaling in tumor microenvironments: mechanism and application","volume":"11","author":"Han","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118543_bib6","article-title":"Paclitaxel for breast cancer therapy: a review on effective drug combination modalities and nano drug delivery platforms","author":"Zenjanab","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118543_bib7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.biotechadv.2016.04.005","article-title":"Hypoxic tumor microenvironment: opportunities to develop targeted therapies","volume":"34","author":"Patel","year":"2016","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.biopha.2025.118543_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2025.101626","article-title":"For and against tumor microenvironment: nanoparticle-based strategies for active cancer therapy","author":"Karimi","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biopha.2025.118543_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116951","article-title":"Recent advances in biomimetic cell membrane\u2013camouflaged nanoparticles for cancer therapy","volume":"177","author":"Alimohammadvand","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.biopha.2025.118543_bib10","doi-asserted-by":"crossref","first-page":"10875","DOI":"10.1021\/acsomega.3c09782","article-title":"Hyaluronic acid-targeted niosomes for effective breast cancer chemostarvation therapy","volume":"9","author":"Kaveh Zenjanab","year":"2024","journal-title":"ACS Omega"},{"issue":"5","key":"10.1016\/j.biopha.2025.118543_bib11","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/ad5d9b","article-title":"Codelivery of methotrexate and silibinin by niosome nanoparticles for enhanced chemotherapy of CT26 colon cancer cells","volume":"19","author":"Sharifi-Azad","year":"2024","journal-title":"Biomed. Mater."},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12896-024-00939-1","article-title":"Aripiprazole-loaded niosome\/chitosan-gold nanoparticles for breast cancer chemo-photo therapy","volume":"24","author":"Alimohammadvand","year":"2024","journal-title":"BMC Biotechnol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118543_bib13","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/ad2ed5","article-title":"Niosomes containing paclitaxel and gold nanoparticles with different coating agents for efficient chemo\/photothermal therapy of breast cancer","volume":"19","author":"Zenjanab","year":"2024","journal-title":"Biomed. Mater."},{"issue":"30","key":"10.1016\/j.biopha.2025.118543_bib14","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1002\/adfm.201600676","article-title":"Modulation of hypoxia in solid tumor microenvironment with MnO2 nanoparticles to enhance photodynamic therapy","volume":"26","author":"Zhu","year":"2016","journal-title":"Adv. Funct. Mater."},{"issue":"10","key":"10.1016\/j.biopha.2025.118543_bib15","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1021\/mp300193f","article-title":"Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth","volume":"9","author":"Liu","year":"2012","journal-title":"Mol. Pharm."},{"issue":"41","key":"10.1016\/j.biopha.2025.118543_bib16","doi-asserted-by":"crossref","first-page":"17254","DOI":"10.1039\/D1NR03387E","article-title":"Normalization of the tumor microvasculature based on targeting and modulation of the tumor microenvironment","volume":"13","author":"Li","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2025.118543_bib17","series-title":"in Seminars in cancer biology","article-title":"Tumor hypoxia: from basic knowledge to therapeutic implications","author":"Liao","year":"2023"},{"issue":"9","key":"10.1016\/j.biopha.2025.118543_bib18","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3390\/cells8091083","article-title":"Improving cancer immunotherapy by targeting the hypoxic tumor microenvironment: new opportunities and challenges","volume":"8","author":"Noman","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.118543_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/HP.S133231","article-title":"A review of the development of tumor vasculature and its effects on the tumor microenvironment","author":"Forster","year":"2017","journal-title":"Hypoxia"},{"key":"10.1016\/j.biopha.2025.118543_bib20","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3389\/fendo.2018.00668","article-title":"Does hypoxia decrease the metabolic rate?","volume":"9","author":"Gu","year":"2018","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118543_bib21","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1073\/pnas.97.6.2826","article-title":"Mitochondrial dysfunction during hypoxia\/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates","volume":"97","author":"Weinberg","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118543_bib22","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s43440-023-00504-1","article-title":"The warburg effect: a score for many instruments in the concert of cancer and cancer niche cells","volume":"75","author":"Jaworska","year":"2023","journal-title":"Pharmacol. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2025.118543_bib23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrc3726","article-title":"Hypoxia and the extracellular matrix: drivers of tumour metastasis","volume":"14","author":"Gilkes","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2025.118543_bib24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/imm.12380","article-title":"Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment","volume":"143","author":"Kumar","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2025.118543_bib25","article-title":"Role of hypoxia in the tumor microenvironment and targeted therapy","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118543_bib26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bbabio.2010.10.012","article-title":"Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma?","volume":"1807","author":"Jose","year":"2011","journal-title":"Biochim. Et. Biophys. Acta (BBA)Bioenerg."},{"key":"10.1016\/j.biopha.2025.118543_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01096-0","article-title":"Nanomaterials for cancer therapy: current progress and perspectives","volume":"14","author":"Cheng","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118543_bib28","first-page":"63","article-title":"Applications and characteristics of nanomaterials in industrial environment","volume":"3","author":"Sharma","year":"2013","journal-title":"Res Dev."},{"issue":"11","key":"10.1016\/j.biopha.2025.118543_bib29","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1039\/c000682n","article-title":"Functional nanoprobes for ultrasensitive detection of biomolecules","volume":"39","author":"Song","year":"2010","journal-title":"Chem. Soc. Rev."},{"issue":"16","key":"10.1016\/j.biopha.2025.118543_bib30","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.3390\/nano12162826","article-title":"Recent advances in functionalized nanoparticles in cancer theranostics","volume":"12","author":"Siddique","year":"2022","journal-title":"Nanomaterials"},{"issue":"3","key":"10.1016\/j.biopha.2025.118543_bib31","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3390\/ijms23031685","article-title":"Nanoparticles in clinical translation for cancer therapy","volume":"23","author":"Mundekkad","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","article-title":"Smart nanoparticles for cancer therapy","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2025.118543_bib33","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.2147\/IJN.S321416","article-title":"Nanoparticle-mediated targeted drug delivery to remodel tumor microenvironment for cancer therapy","author":"Tang","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.biopha.2025.118543_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.31083\/j.fbl2705145","article-title":"Recent advancements of nanotechnology-based strategies for overcoming tumor microenvironment hypoxia","volume":"27","author":"Wu","year":"2022","journal-title":"Front. Biosci. Landmark"},{"key":"10.1016\/j.biopha.2025.118543_bib35","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jconrel.2017.03.013","article-title":"Exploiting the cancer niche: tumor-associated macrophages and hypoxia as promising synergistic targets for nano-based therapy","volume":"253","author":"Silva","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2025.118543_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2019.12.041","article-title":"Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: an up-to-date review","volume":"319","author":"Kumari","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2025.118543_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.158081","article-title":"Nanoparticle-Based drug delivery strategies for targeted therapy to hypoxic solid tumors","author":"Wu","year":"2024","journal-title":"Chem. Eng. J."},{"issue":"39","key":"10.1016\/j.biopha.2025.118543_bib38","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.1039\/D1TB01437D","article-title":"A photo and tumor microenvironment activated nano-enzyme with enhanced ROS generation and hypoxia relief for efficient cancer therapy","volume":"9","author":"Chen","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"3","key":"10.1016\/j.biopha.2025.118543_bib39","doi-asserted-by":"crossref","first-page":"634","DOI":"10.34172\/apb.2024.054","article-title":"Dual-stage acting dendrimeric nanoparticle for deepened chemotherapeutic drug delivery to tumor cells","volume":"14","author":"Shahpouri","year":"2024","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.biopha.2025.118543_bib40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.biomaterials.2017.01.001","article-title":"Development of a hypoxia-triggered and hypoxic radiosensitized liposome as a doxorubicin carrier to promote synergetic chemo-\/radio-therapy for glioma","volume":"121","author":"Liu","year":"2017","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.biopha.2025.118543_bib41","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.biomaterials.2013.11.022","article-title":"Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery","volume":"35","author":"Thambi","year":"2014","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.biopha.2025.118543_bib42","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.7150\/thno.55441","article-title":"Calcium phosphate engineered photosynthetic microalgae to combat hypoxic-tumor by in-situ modulating hypoxia and cascade radio-phototherapy","volume":"11","author":"Zhong","year":"2021","journal-title":"Theranostics"},{"issue":"29","key":"10.1016\/j.biopha.2025.118543_bib43","doi-asserted-by":"crossref","first-page":"6932","DOI":"10.1039\/C9SC02107H","article-title":"Strategies based on metal-based nanoparticles for hypoxic-tumor radiotherapy","volume":"10","author":"Zhang","year":"2019","journal-title":"Chem. Sci."},{"key":"10.1016\/j.biopha.2025.118543_bib44","doi-asserted-by":"crossref","first-page":"1436297","DOI":"10.3389\/fbioe.2024.1436297","article-title":"Metal-based nanoparticle in cancer treatment: lessons learned and challenges","volume":"12","author":"Hheidari","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118543_bib45","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/cancers13040606","article-title":"The oxygen-generating calcium peroxide-modified magnetic nanoparticles attenuate hypoxia-induced chemoresistance in triple-negative breast cancer","volume":"13","author":"Cheng","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118543_bib46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jconrel.2024.07.031","article-title":"Palladium nanocrystals regulates scleral extracellular matrix remodeling in myopic progression by modulating the hypoxia signaling pathway Nrf-2\/Ho-1","volume":"373","author":"Zhang","year":"2024","journal-title":"J. Control. Release"},{"issue":"17","key":"10.1016\/j.biopha.2025.118543_bib47","doi-asserted-by":"crossref","first-page":"1910395","DOI":"10.1002\/adfm.201910395","article-title":"Photosynthetic biohybrid nanoswimmers system to alleviate tumor hypoxia for FL\/PA\/MR imaging-guided enhanced radio-photodynamic synergetic therapy","volume":"30","author":"Zhong","year":"2020","journal-title":"Adv. Funct. Mater."},{"issue":"10","key":"10.1016\/j.biopha.2025.118543_bib48","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2025.118543_bib49","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3390\/cancers13050988","article-title":"HIF-prolyl hydroxylase domain proteins (PHDs) in cancer\u2014Potential targets for anti-tumor therapy?","volume":"13","author":"Gaete","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib50","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.trecan.2021.10.004","article-title":"Revisiting the HIF switch in the tumor and its immune microenvironment","volume":"8","author":"Cowman","year":"2022","journal-title":"Trends Cancer"},{"issue":"10","key":"10.1016\/j.biopha.2025.118543_bib51","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3390\/pharmaceutics16101286","article-title":"Targeting Hypoxia-Inducible Factor-1\u03b1 in pancreatic cancer: siRNA delivery using hyaluronic Acid-Displaying nanoparticles","volume":"16","author":"Spadea","year":"2024","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.biopha.2025.118543_bib52","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.18240\/ijo.2022.11.03","article-title":"A trojan horse biomimetic delivery system using mesenchymal stem cells for HIF-1\u03b1 siRNA-loaded nanoparticles on retinal pigment epithelial cells under hypoxia environment","volume":"15","author":"Zhang","year":"2022","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118543_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2021.102373","article-title":"Blockade of HIF-1\u03b1 and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanoparticles loaded with siRNA molecules prevents tumor growth","volume":"34","author":"Budi","year":"2021","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"10","key":"10.1016\/j.biopha.2025.118543_bib54","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3390\/pharmaceutics16101286","article-title":"Targeting Hypoxia-Inducible Factor-1\u03b1 in pancreatic cancer: siRNA delivery using hyaluronic Acid-Displaying nanoparticles","volume":"16","author":"Spadea","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib55","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12951-023-01960-w","article-title":"Biomimetic hypoxia-triggered RNAi nanomedicine for synergistically mediating chemo\/radiotherapy of glioblastoma","volume":"21","author":"Wang","year":"2023","journal-title":"J. Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib56","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12935-024-03393-3","article-title":"The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of heme oxygenase-1 and hypoxia-inducible factor 1-alpha","volume":"24","author":"Sadeghi","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"31","key":"10.1016\/j.biopha.2025.118543_bib57","doi-asserted-by":"crossref","first-page":"31461","DOI":"10.18632\/oncotarget.5058","article-title":"Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells","volume":"6","author":"Kopecka","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118543_bib58","first-page":"5049","article-title":"Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells","author":"Liu","year":"2016","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.biopha.2025.118543_bib59","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.2147\/IJN.S109695","article-title":"Silver nanoparticles inhibit the function of hypoxia-inducible factor-1 and target genes: insight into the cytotoxicity and antiangiogenesis","author":"Yang","year":"2016","journal-title":"Int. J. Nanomed."},{"issue":"12","key":"10.1016\/j.biopha.2025.118543_bib60","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1021\/bc200406n","article-title":"In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles","volume":"22","author":"Jin","year":"2011","journal-title":"Bioconjugate Chem."},{"issue":"10","key":"10.1016\/j.biopha.2025.118543_bib61","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3390\/ph17101389","article-title":"Targeting tumor hypoxia with Nanoparticle-Based therapies: challenges, opportunities, and clinical implications","volume":"17","author":"Debnath","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib62","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/s12951-022-01752-8","article-title":"Acidic and hypoxic tumor microenvironment regulation by CaO2-loaded polydopamine nanoparticles","volume":"20","author":"Ruan","year":"2022","journal-title":"J. nanobiotechnology"},{"key":"10.1016\/j.biopha.2025.118543_bib63","doi-asserted-by":"crossref","first-page":"1039378","DOI":"10.3389\/fonc.2022.1039378","article-title":"Recent advances of nanomaterial-based anti-angiogenic therapy in tumor vascular normalization and immunotherapy","volume":"12","author":"Xiao","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib64","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijpharm.2014.10.065","article-title":"The enhancement of gene silencing efficiency with chitosan-coated liposome formulations of siRNAs targeting HIF-1\u03b1 and VEGF","volume":"478","author":"\u015ealva","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118543_bib65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2014.12.028","article-title":"Co-delivery of HIF1\u03b1 siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer","volume":"46","author":"Zhao","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.118543_bib66","first-page":"1375","article-title":"Nanoformulation of D-\u03b1-tocopheryl polyethylene glycol 1000 succinate-b-poly (\u03b5-caprolactone-ran-glycolide) diblock copolymer for siRNA targeting HIF-1\u03b1 for nasopharyngeal carcinoma therapy","author":"Chen","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2025.118543_bib67","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.2147\/IJN.S142739","article-title":"VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancer","author":"Chen","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"7","key":"10.1016\/j.biopha.2025.118543_bib68","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1021\/acs.molpharmaceut.6b00227","article-title":"Dynamic contrast enhanced MRI assessing the antiangiogenic effect of silencing HIF-1\u03b1 with targeted multifunctional ECO\/siRNA nanoparticles","volume":"13","author":"Malamas","year":"2016","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib69","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.canlet.2014.12.052","article-title":"Nanoparticle delivery of HIF1\u03b1 siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer","volume":"359","author":"Chen","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2025.118543_bib70","article-title":"Activating mitochondrial complex I by polyphenol nanoparticle to inhibit Hypoxia-Inducible Factor-1 subunit \u03b1 for immunotherapy","author":"Xu","year":"2025","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2025.118543_bib71","article-title":"MUC1 aptamer-conjugated niclosamide-loaded PLGA-PEG nanoparticles attenuate HIF-1 stabilization upon hypoxia in MCF7 breast cancer cells","volume":"92","author":"Eskandani","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biopha.2025.118543_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.compositesb.2022.110117","article-title":"Boosting the anti-tumor performance of disulfiram against glioblastoma by using ultrasmall nanoparticles and HIF-1\u03b1 inhibitor","volume":"243","author":"Yang","year":"2022","journal-title":"Composites Part B Engineering"},{"issue":"10","key":"10.1016\/j.biopha.2025.118543_bib73","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1021\/acs.nanolett.6b02365","article-title":"Ultrasound triggered tumor oxygenation with oxygen-shuttle nanoperfluorocarbon to overcome hypoxia-associated resistance in cancer therapies","volume":"16","author":"Song","year":"2016","journal-title":"Nano Lett."},{"issue":"2","key":"10.1016\/j.biopha.2025.118543_bib74","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/jcp.29957","article-title":"Hyaluronic acid optimises therapeutic effects of hydrogen peroxide-induced oxidative stress on breast cancer","volume":"236","author":"Abbasi","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2025.118543_bib75","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00424-020-02482-2","article-title":"Perfluorocarbon-based oxygen carriers: from physics to physiology","volume":"473","author":"J\u00e4gers","year":"2021","journal-title":"Pfl\u00fcgers Arch. Eur. J. Physiol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118543_bib76","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1039\/C8BM00852C","article-title":"Fluorinated polymeric micelles to overcome hypoxia and enhance photodynamic cancer therapy","volume":"6","author":"Wang","year":"2018","journal-title":"Biomater. Sci."},{"issue":"14","key":"10.1016\/j.biopha.2025.118543_bib77","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1002\/adma.201504617","article-title":"Perfluorocarbon-loaded hollow Bi2Se3 nanoparticles for timely supply of oxygen under near-infrared light to enhance the radiotherapy of cancer","volume":"28","author":"Song","year":"2016","journal-title":"Adv. Mater. (Deerfield Beach Fla. )"},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib78","doi-asserted-by":"crossref","first-page":"23393","DOI":"10.1038\/srep23393","article-title":"Self-monitoring artificial red cells with sufficient oxygen supply for enhanced photodynamic therapy","volume":"6","author":"Luo","year":"2016","journal-title":"Sci. Rep."},{"issue":"35","key":"10.1016\/j.biopha.2025.118543_bib79","doi-asserted-by":"crossref","first-page":"1701429","DOI":"10.1002\/adma.201701429","article-title":"Erythrocyte-membrane-enveloped perfluorocarbon as nanoscale artificial red blood cells to relieve tumor hypoxia and enhance cancer radiotherapy","volume":"29","author":"Gao","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2025.118543_bib80","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.actbio.2025.01.017","article-title":"Dually fluorinated unimolecular micelles for stable oxygen-carrying and enhanced photosensitive efficiency to boost photodynamic therapy against hypoxic tumors","volume":"193","author":"Zhang","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2025.118543_bib81","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jcis.2021.10.082","article-title":"An all-in-one nanoplatform with near-infrared light promoted on-demand oxygen release and deep intratumoral penetration for synergistic photothermal\/photodynamic therapy","volume":"608","author":"Liu","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.biopha.2025.118543_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-016-1033-3","article-title":"Liposome encapsulated perfluorohexane enhances radiotherapy in mice without additional oxygen supply","volume":"14","author":"Xu","year":"2016","journal-title":"J. Transl. Med."},{"issue":"9","key":"10.1016\/j.biopha.2025.118543_bib83","doi-asserted-by":"crossref","first-page":"8715","DOI":"10.1021\/acsnano.6b04156","article-title":"Carbon-dot-decorated carbon nitride nanoparticles for enhanced photodynamic therapy against hypoxic tumor via water splitting","volume":"10","author":"Zheng","year":"2016","journal-title":"ACS nano"},{"issue":"17","key":"10.1016\/j.biopha.2025.118543_bib84","doi-asserted-by":"crossref","first-page":"16715","DOI":"10.1021\/acsnano.3c03169","article-title":"Bifunctional cascading nanozymes based on carbon dots promotes photodynamic therapy by regulating hypoxia and glycolysis","volume":"17","author":"Luo","year":"2023","journal-title":"ACS nano"},{"issue":"33","key":"10.1016\/j.biopha.2025.118543_bib85","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1002\/adma.201601902","article-title":"Intelligent Albumin-MnO2 nanoparticles as pH-\/H2 O2-Responsive dissociable nanocarriers to modulate tumor hypoxia for effective combination therapy","volume":"28","author":"Chen","year":"2016","journal-title":"Adv. Mater. (Deerfield Beach Fla. )"},{"issue":"20","key":"10.1016\/j.biopha.2025.118543_bib86","doi-asserted-by":"crossref","first-page":"12977","DOI":"10.1021\/acsomega.0c05922","article-title":"Doxorubicin-loaded MnO2@ zeolitic imidazolate framework-8 nanoparticles as a chemophotothermal system for lung cancer therapy","volume":"6","author":"Tan","year":"2021","journal-title":"ACS Omega"},{"issue":"26","key":"10.1016\/j.biopha.2025.118543_bib87","doi-asserted-by":"crossref","first-page":"33021","DOI":"10.1021\/acsami.4c04361","article-title":"Aggregation-Induced emission CN-Based nanoparticles to alleviate hypoxic liver fibrosis via triggering HSC ferroptosis and enhancing photodynamic therapy","volume":"16","author":"Liu","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2025.118543_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121064","article-title":"Ruthenium (II) complexes coordinated to graphitic carbon nitride: oxygen self-sufficient photosensitizers which produce multiple ROS for photodynamic therapy in hypoxia","volume":"276","author":"Wei","year":"2021","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.biopha.2025.118543_bib89","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1021\/acsnano.8b02977","article-title":"Normalizing tumor microenvironment based on photosynthetic abiotic\/biotic nanoparticles","volume":"12","author":"Zheng","year":"2018","journal-title":"ACS nano"},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib90","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1021\/acsnano.1c07504","article-title":"A cascade nanozyme with amplified sonodynamic therapeutic effects through comodulation of hypoxia and immunosuppression against cancer","volume":"16","author":"Tao","year":"2021","journal-title":"ACS nano"},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib91","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1039\/D1BM01710A","article-title":"Hypoxia-alleviated sonodynamic therapy based on a hybrid protein oxygen carrier to enhance tumor inhibition","volume":"10","author":"Yin","year":"2022","journal-title":"Biomater. Sci."},{"issue":"18","key":"10.1016\/j.biopha.2025.118543_bib92","doi-asserted-by":"crossref","first-page":"16367","DOI":"10.1021\/acsami.9b03541","article-title":"Light-enhanced O2-evolving nanoparticles boost photodynamic therapy to elicit antitumor immunity","volume":"11","author":"Wang","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"7","key":"10.1016\/j.biopha.2025.118543_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.109171","article-title":"O2-generating multifunctional polymeric micelles for highly efficient and selective photodynamic-photothermal therapy in melanoma","volume":"35","author":"Qin","year":"2024","journal-title":"Chin. Chem. Lett."},{"issue":"42","key":"10.1016\/j.biopha.2025.118543_bib94","doi-asserted-by":"crossref","first-page":"2303254","DOI":"10.1002\/adfm.202303254","article-title":"Bioactive bacteria\/MOF hybrids can achieve targeted synergistic chemotherapy and chemodynamic therapy against breast tumors","volume":"33","author":"Li","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"46","key":"10.1016\/j.biopha.2025.118543_bib95","doi-asserted-by":"crossref","first-page":"2402308","DOI":"10.1002\/smll.202402308","article-title":"Zinc coordination lipid nanoparticles co-Delivering calcium peroxide and chelating STING agonist for enhanced cancer metalloimmunotherapy","volume":"20","author":"Qiu","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.biopha.2025.118543_bib96","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jconrel.2023.05.023","article-title":"Drug induced mitochondria dysfunction to enhance photodynamic therapy of hypoxic tumors","volume":"358","author":"Cen","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2025.118543_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-01196-6","article-title":"Mitochondria-targeted nanoplatforms for enhanced photodynamic therapy against hypoxia tumor","volume":"19","author":"Wen","year":"2021","journal-title":"J. Nanobiotechnology"},{"issue":"2","key":"10.1016\/j.biopha.2025.118543_bib98","first-page":"1784","article-title":"O2 economizer for inhibiting cell respiration to combat the hypoxia obstacle in tumor treatments","volume":"13","author":"Yu","year":"2019","journal-title":"Acs Nano"},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib99","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40824-022-00296-0","article-title":"Oxygen tank for synergistic hypoxia relief to enhance mitochondria-targeted photodynamic therapy","volume":"26","author":"Li","year":"2022","journal-title":"Biomater. Res."},{"key":"10.1016\/j.biopha.2025.118543_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2019.03.001","article-title":"A traceable nanoplatform for enhanced chemo-photodynamic therapy by reducing oxygen consumption","volume":"20","author":"Yao","year":"2019","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"5","key":"10.1016\/j.biopha.2025.118543_bib101","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1667\/RR1744.1","article-title":"Decrease in tumor cell oxygen consumption after treatment with vandetanib (ZACTIMA\u2122; ZD6474) and its effect on response to radiotherapy","volume":"172","author":"Ansiaux","year":"2009","journal-title":"Radiat. Res."},{"issue":"12","key":"10.1016\/j.biopha.2025.118543_bib102","doi-asserted-by":"crossref","first-page":"2100198","DOI":"10.1002\/adhm.202100198","article-title":"Mitochondria targeted O2 economizer to alleviate tumor hypoxia for enhanced photodynamic therapy","volume":"10","author":"Yuan","year":"2021","journal-title":"Adv. Healthc. Mater."},{"issue":"3","key":"10.1016\/j.biopha.2025.118543_bib103","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/jcp.29126","article-title":"Nanoparticles and cancer therapy: perspectives for application of nanoparticles in the treatment of cancers","volume":"235","author":"Aghebati-Maleki","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118543_bib104","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrd3455","article-title":"Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases","volume":"10","author":"Carmeliet","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2025.118543_bib105","series-title":"in Nano-Enabled Medical Applications","first-page":"279","article-title":"Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner","author":"Chauhan","year":"2020"},{"key":"10.1016\/j.biopha.2025.118543_bib106","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.biomaterials.2017.09.021","article-title":"Tumor vasculature normalization by orally fed erlotinib to modulate the tumor microenvironment for enhanced cancer nanomedicine and immunotherapy","volume":"148","author":"Chen","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.118543_bib107","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.2147\/IJN.S128802","article-title":"Gold nanoparticles attenuate metastasis by tumor vasculature normalization and epithelial\u2013mesenchymal transition inhibition","author":"Li","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib108","doi-asserted-by":"crossref","first-page":"30619","DOI":"10.1038\/srep30619","article-title":"Gold nanoparticle\u2013mediated targeted delivery of recombinant human endostatin normalizes tumour vasculature and improves cancer therapy","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2025.118543_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236245","article-title":"Noninvasive imaging of tumor hypoxia after nanoparticle-mediated tumor vascular disruption","volume":"15","author":"Virani","year":"2020","journal-title":"Plos One"},{"issue":"9","key":"10.1016\/j.biopha.2025.118543_bib110","doi-asserted-by":"crossref","first-page":"8689","DOI":"10.1021\/acsnano.5b02028","article-title":"Remodeling tumor vasculature to enhance delivery of intermediate-sized nanoparticles","volume":"9","author":"Jiang","year":"2015","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2025.118543_bib111","doi-asserted-by":"crossref","DOI":"10.34133\/bmr.0144","article-title":"Lipid nanoparticle delivery system for normalization of tumor microenvironment and tumor vascular structure","author":"Ha","year":"2025","journal-title":"Biomater. Res."},{"issue":"7","key":"10.1016\/j.biopha.2025.118543_bib112","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1021\/acsnano.9b08460","article-title":"Gold nanoparticles induce tumor vessel normalization and impair metastasis by inhibiting endothelial Smad2\/3 signaling","volume":"14","author":"Huang","year":"2020","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2025.118543_bib113","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jconrel.2017.09.004","article-title":"Oxygen generating nanoparticles for improved photodynamic therapy of hypoxic tumours","volume":"264","author":"Sheng","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2025.118543_bib114","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.biomaterials.2016.10.020","article-title":"TaOx decorated perfluorocarbon nanodroplets as oxygen reservoirs to overcome tumor hypoxia and enhance cancer radiotherapy","volume":"112","author":"Song","year":"2017","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.biopha.2025.118543_bib115","doi-asserted-by":"crossref","first-page":"12849","DOI":"10.1021\/acsnano.7b08225","article-title":"Oxygen-self-produced nanoplatform for relieving hypoxia and breaking resistance to sonodynamic treatment of pancreatic cancer","volume":"11","author":"Chen","year":"2017","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2025.118543_bib116","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.biomaterials.2017.02.017","article-title":"Orthogonal near-infrared upconversion co-regulated site-specific O2 delivery and photodynamic therapy for hypoxia tumor by using red blood cell microcarriers","volume":"125","author":"Wang","year":"2017","journal-title":"Biomaterials"},{"issue":"40","key":"10.1016\/j.biopha.2025.118543_bib117","doi-asserted-by":"crossref","first-page":"44407","DOI":"10.1021\/acsami.0c08473","article-title":"Nanoparticle delivery of MnO2 and antiangiogenic therapy to overcome hypoxia-driven tumor escape and suppress hepatocellular carcinoma","volume":"12","author":"Chang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.biopha.2025.118543_bib118","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1021\/nn405773r","article-title":"Multifunctional albumin\u2013MnO2 nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response","volume":"8","author":"Prasad","year":"2014","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2025.118543_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100907","article-title":"Graphdiyne-templated palladium-nanoparticle assembly as a robust oxygen generator to attenuate tumor hypoxia","volume":"34","author":"Liu","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.biopha.2025.118543_bib120","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1007\/s12274-016-1205-8","article-title":"Core\u2013shell au@ MnO 2 nanoparticles for enhanced radiotherapy via improving the tumor oxygenation","volume":"9","author":"Yi","year":"2016","journal-title":"Nano Res."},{"key":"10.1016\/j.biopha.2025.118543_bib121","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.actbio.2018.09.017","article-title":"Platelet-mimicking nanoparticles co-loaded with W18O49 and metformin alleviate tumor hypoxia for enhanced photodynamic therapy and photothermal therapy","volume":"80","author":"Zuo","year":"2018","journal-title":"Acta Biomater."},{"issue":"10","key":"10.1016\/j.biopha.2025.118543_bib122","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1021\/acs.accounts.8b00214","article-title":"Modulating hypoxia via nanomaterials chemistry for efficient treatment of solid tumors","volume":"51","author":"Liu","year":"2018","journal-title":"Acc. Chem. Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118543_bib123","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1039\/C8BM01350K","article-title":"Attempts to strengthen and simplify the tumor vascular normalization strategy using tumor vessel normalization promoting nanomedicines","volume":"7","author":"Du","year":"2019","journal-title":"Biomater. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2025.118543_bib124","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/sj.gt.3300468","article-title":"Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment","volume":"4","author":"Lemmon","year":"1997","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canlet.2007.10.034","article-title":"Bacterial targeted tumour therapy-Dawn of a new era","volume":"259","author":"Wei","year":"2008","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.biopha.2025.118543_bib126","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nnano.2016.137","article-title":"Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions","volume":"11","author":"Felfoul","year":"2016","journal-title":"Nat. Nanotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118543_bib127","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1021\/acs.nanolett.6b00262","article-title":"Bacteria-mediated hypoxia-specific delivery of nanoparticles for tumors imaging and therapy","volume":"16","author":"Luo","year":"2016","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib128","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41551-021-00772-3","article-title":"Enhancing the tropism of bacteria via genetically programmed biosensors","volume":"6","author":"Chien","year":"2022","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib129","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41467-023-37225-1","article-title":"Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field","volume":"14","author":"Ma","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118543_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.135566","article-title":"Anaerobic bacteria mediated \u2018smart missile\u2019targeting tumor hypoxic area enhances the therapeutic outcome of lung cancer","volume":"438","author":"Li","year":"2022","journal-title":"Chem. Eng. J."},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib131","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12951-022-01373-1","article-title":"Bacteria-driven hypoxia targeting delivery of chemotherapeutic drug proving outcome of breast cancer","volume":"20","author":"Xiao","year":"2022","journal-title":"J. Nanobiotechnology"},{"issue":"5","key":"10.1016\/j.biopha.2025.118543_bib132","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2217\/nnm.14.13","article-title":"Macrophages associated with tumors as potential targets and therapeutic intermediates","volume":"9","author":"Vinogradov","year":"2014","journal-title":"Nanomedicine"},{"issue":"4","key":"10.1016\/j.biopha.2025.118543_bib133","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1084\/jem.20150295","article-title":"The interaction of anticancer therapies with tumor-associated macrophages","volume":"212","author":"Mantovani","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2025.118543_bib134","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biomaterials.2015.08.033","article-title":"Tumortropic monocyte-mediated delivery of echogenic polymer bubbles and therapeutic vesicles for chemotherapy of tumor hypoxia","volume":"71","author":"Huang","year":"2015","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.biopha.2025.118543_bib135","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7150\/thno.85917","article-title":"Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors","volume":"14","author":"Zheng","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib136","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.apsb.2023.08.012","article-title":"Cancer cell membrane-coated bacterial ghosts for highly efficient paclitaxel delivery against metastatic lung cancer","volume":"14","author":"Ling","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2025.118543_bib137","first-page":"283","article-title":"Engineered bacterial membrane biomimetic covalent organic framework as nano-immunopotentiator for cancer immunotherapy","volume":"47","author":"Yang","year":"2025","journal-title":"Bioact. Mater."},{"issue":"21","key":"10.1016\/j.biopha.2025.118543_bib138","doi-asserted-by":"crossref","first-page":"20875","DOI":"10.1021\/acsnano.3c07763","article-title":"Nanomedicine strategies in conquering and utilizing the cancer hypoxia environment","volume":"17","author":"Pan","year":"2023","journal-title":"Acs Nano"},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib139","doi-asserted-by":"crossref","first-page":"1900083","DOI":"10.1002\/adtp.201900083","article-title":"Nanomedicine-Enabled modulation of tumor hypoxic microenvironment for enhanced cancer therapy","volume":"3","author":"Wang","year":"2020","journal-title":"Adv. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2025.118543_bib140","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00280-015-2920-7","article-title":"Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs","volume":"77","author":"Phillips","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"13","key":"10.1016\/j.biopha.2025.118543_bib141","doi-asserted-by":"crossref","first-page":"eabc5267","DOI":"10.1126\/sciadv.abc5267","article-title":"Exploiting the acquired vulnerability of cisplatin-resistant tumors with a hypoxia-amplifying DNA repair\u2013inhibiting (HYDRI) nanomedicine","volume":"7","author":"Chen","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2025.118543_bib142","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jcis.2023.12.149","article-title":"A two-stage exacerbated hypoxia nanoengineering strategy induced amplifying activation of tirapazamine for microwave hyperthermia-chemotherapy of breast cancer","volume":"659","author":"Zhao","year":"2024","journal-title":"J. Colloid Interface Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118543_bib143","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1021\/acsnano.6b08731","article-title":"Tumor-penetrating nanoparticles for enhanced anticancer activity of combined photodynamic and hypoxia-activated therapy","volume":"11","author":"Wang","year":"2017","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2025.118543_bib144","article-title":"Design and synthesis of new hypoxia-activated prodrug antibody-conjugated derivative of the toll-like receptor agonist resiquimod: a proof-of-concept study to increase tumour uptake","author":"Anduran","year":"2022","journal-title":"Bioreductive Act. Prodrugs Target Tumour Hypoxia"},{"issue":"9","key":"10.1016\/j.biopha.2025.118543_bib145","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1166\/nnl.2020.3211","article-title":"Targeting mesoporous silica for synergistic TH-302 and afatinib delivery to nasopharyngeal carcinoma","volume":"12","author":"Zhang","year":"2020","journal-title":"Nanosci. Nanotechnol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib146","article-title":"The role of Hypoxia-Inducible Factor-1\u03b1, glucose Transporter-1,(GLUT-1) and carbon anhydrase IX in endometrial cancer patients","volume":"2014","author":"Sadlecki","year":"2014","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.biopha.2025.118543_bib147","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jconrel.2019.01.006","article-title":"Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells","volume":"295","author":"Yi","year":"2019","journal-title":"J. Control. Release"},{"issue":"36","key":"10.1016\/j.biopha.2025.118543_bib148","doi-asserted-by":"crossref","first-page":"9097","DOI":"10.1200\/JCO.2005.01.3771","article-title":"Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non\u2013small-cell lung cancer: southwest oncology group trial S0003","volume":"23","author":"Williamson","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.biopha.2025.118543_bib149","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1200\/JCO.2008.21.3868","article-title":"Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222","volume":"27","author":"Le","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118543_bib150","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1200\/JCO.1998.16.11.3524","article-title":"Tirapazamine with cisplatin in patients with advanced non-small-cell lung cancer: a phase II study","volume":"16","author":"Treat","year":"1998","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.biopha.2025.118543_bib151","first-page":"5970","article-title":"Multicellular resistance to tirapazamine is due to restricted extravascular transport: a pharmacokinetic\/pharmacodynamic study in HT29 multicellular layer cultures","volume":"63","author":"Hicks","year":"2003","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib152","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1038\/s41598-021-81841-0","article-title":"Phase 2 trial of hypoxia activated evofosfamide (TH302) for treatment of recurrent bevacizumab-refractory glioblastoma","volume":"11","author":"Brenner","year":"2021","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2025.118543_bib153","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/0959-8049(96)00120-7","article-title":"Phase I pharmacokinetics and limited sampling strategies for the bioreductive alkylating drug EO9","volume":"32","author":"McLeod","year":"1996","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2025.118543_bib154","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.juro.2006.06.007","article-title":"Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response","volume":"176","author":"van der Heijden","year":"2006","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118543_bib155","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.juro.2008.03.031","article-title":"Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer","volume":"180","author":"Hendricksen","year":"2008","journal-title":"J. Urol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118543_bib156","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1158\/1078-0432.CCR-07-4020","article-title":"Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors: results of a phase I study","volume":"14","author":"Albertella","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"21","key":"10.1016\/j.biopha.2025.118543_bib157","doi-asserted-by":"crossref","first-page":"7110","DOI":"10.1158\/1078-0432.CCR-08-0483","article-title":"A phase 1 open-label, accelerated dose-escalation study of the hypoxia-activated prodrug AQ4N in patients with advanced malignancies","volume":"14","author":"Papadopoulos","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2025.118543_bib158","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/annonc\/mdm120","article-title":"The use of pharmacokinetic and pharmacodynamic end points to determine the dose of AQ4N, a novel hypoxic cell cytotoxin, given with fractionated radiotherapy in a phase I study","volume":"18","author":"Steward","year":"2007","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118543_bib159","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00204-023-03670-6","article-title":"TH-4000, a hypoxia-activated pan-HER inhibitor, shows excellent preclinical efficacy for the treatment of HER2+ breast cancer","volume":"98","author":"Shao","year":"2024","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2025.118543_bib160","article-title":"Oxygen-based nanocarriers to modulate tumor hypoxia for ameliorated anti-tumor therapy: fabrications, properties, and future directions","volume":"8","author":"Li","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biopha.2025.118543_bib161","series-title":"Pharmaceutical Process Engineering and Scale-up Principles","first-page":"173","article-title":"Scale-up of nanoparticle manufacturing process","author":"Fernandes","year":"2023"},{"key":"10.1016\/j.biopha.2025.118543_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102314","article-title":"Toward the scale-up production of polymeric nanotherapeutics for cancer clinical trials","volume":"56","author":"Mahmud","year":"2024","journal-title":"Nano Today"},{"issue":"2","key":"10.1016\/j.biopha.2025.118543_bib163","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1021\/acsabm.0c01319","article-title":"Dendrimer architectonics to treat cancer and neurodegenerative diseases with implications in theranostics and personalized Medicine","volume":"4","author":"Moorthy","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"issue":"13","key":"10.1016\/j.biopha.2025.118543_bib164","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.addr.2012.06.006","article-title":"Nanotheranostics for personalized Medicine","volume":"64","author":"Mura","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.118543_bib165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2025.118543_bib166","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/jcp.25859","article-title":"Modulating tumor hypoxia by nanomedicine for effective cancer therapy","volume":"233","author":"Jahanban-Esfahlan","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2025.118543_bib167","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jconrel.2022.12.009","article-title":"Prospects for hypoxia-based drug delivery platforms for the elimination of advanced metastatic tumors: from 3D modeling to clinical concepts","volume":"353","author":"Shahpouri","year":"2023","journal-title":"J. Control. Release"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:50:49Z","timestamp":1772848249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225007371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":167,"alternative-id":["S0753332225007371"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118543","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing nanotechnology to modulate hypoxic tumor microenvironments: Enhanced strategies for oncological innovations","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118543","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118543"}}